ATE347376T1 - Behandlung von allergien - Google Patents

Behandlung von allergien

Info

Publication number
ATE347376T1
ATE347376T1 AT00128661T AT00128661T ATE347376T1 AT E347376 T1 ATE347376 T1 AT E347376T1 AT 00128661 T AT00128661 T AT 00128661T AT 00128661 T AT00128661 T AT 00128661T AT E347376 T1 ATE347376 T1 AT E347376T1
Authority
AT
Austria
Prior art keywords
medicament
treatment
derivative
allergies
allergenic
Prior art date
Application number
AT00128661T
Other languages
English (en)
Inventor
Vera Dr Mahler
Susanne Dr Vrtala
Roland Dr Suck
Oliver Dr Cromwell
Helmut Dr Fiebig
Dietrich Dr Kraft
Rudolf Dr Valenta
Original Assignee
Biomay Prod & Handel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170855&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE347376(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay Prod & Handel filed Critical Biomay Prod & Handel
Application granted granted Critical
Publication of ATE347376T1 publication Critical patent/ATE347376T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00128661T 2000-12-28 2000-12-28 Behandlung von allergien ATE347376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128661A EP1219300B1 (de) 2000-12-28 2000-12-28 Behandlung von Allergien

Publications (1)

Publication Number Publication Date
ATE347376T1 true ATE347376T1 (de) 2006-12-15

Family

ID=8170855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00128661T ATE347376T1 (de) 2000-12-28 2000-12-28 Behandlung von allergien

Country Status (6)

Country Link
US (1) US20020187158A1 (de)
EP (1) EP1219300B1 (de)
AT (1) ATE347376T1 (de)
DE (1) DE60032250T2 (de)
DK (1) DK1219300T3 (de)
HK (1) HK1045941B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US7879977B2 (en) * 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
US8153414B2 (en) * 2000-04-06 2012-04-10 Allertein Therapeutics, Llc Microbial delivery system
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
EP1380290A1 (de) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
US20080254041A1 (en) * 2003-09-11 2008-10-16 Novozymes A/S Method for Selecting an Immunotherapeutic Preparation
US7767212B2 (en) 2005-03-18 2010-08-03 Cytos Biotechnology Ag CAT allergen conjugates and uses thereof
AU2006267176A1 (en) 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Cross-beta structure binding compounds
WO2007008073A2 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. METHODS FOR DETERMINING THE EFFECT OF A TREATMENT ON THE CROSS-ß STRUCTURE CONTENT OF A PROTEIN; SELECTION OF TREATMENTS AND USES THEREOF
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
AT503297B1 (de) * 2006-05-18 2007-09-15 Biomay Ag Allergen-spezifische antikörper
US10546652B2 (en) * 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US8122073B2 (en) * 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US7853626B2 (en) * 2006-09-29 2010-12-14 The Invention Science Fund I, Llc Computational systems for biomedical data
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082271A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082307A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10068303B2 (en) * 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US20080082583A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
EP2058000A1 (de) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Zur Aktivierung von T-Zellen fähige immunogene Zusammensetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633857T2 (de) * 1995-03-28 2005-12-01 Asahi Breweries Ltd. Modifiziertes Allergen N
SE9703531D0 (sv) * 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
PT1062341E (pt) * 1998-03-16 2008-12-24 Alk Abello As Alergénios recombinantes mutantes
US6123456A (en) * 1998-07-01 2000-09-26 General Electric Company Catalytic hydrogenation to remove gas from x-ray tube cooling oil

Also Published As

Publication number Publication date
DE60032250T2 (de) 2007-03-15
EP1219300A1 (de) 2002-07-03
DE60032250D1 (de) 2007-01-18
US20020187158A1 (en) 2002-12-12
DK1219300T3 (da) 2007-03-05
EP1219300B1 (de) 2006-12-06
HK1045941B (en) 2007-06-29
HK1045941A1 (en) 2002-12-20

Similar Documents

Publication Publication Date Title
ATE347376T1 (de) Behandlung von allergien
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
ATE495755T1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
EP1040830A4 (de) Heilmittel für neurodegenerative krankheiten
DE69718150D1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE60231131D1 (de) Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DK0865284T3 (da) Præparater, som indeholder vismut og ét eller flere antimikrobiske midler, til forebyggelse og behandling af gastrointestinale sygdomme
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
RU2002130727A (ru) Способ лечения детей и подростков с латентной туберкулезной инфекцией
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
DK0865287T3 (da) Præparater indeholdende bismuth til forebyggelse og behandling af gastrointestinale lidelser
RU2001124669A (ru) Способ профилактики паратифа телят
RU2000108989A (ru) Способ профилактики и лечения респираторных болезней телят
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties